| Product Type | Impurity Standards |
| CAT. No. | MRL-A33001 |
| CAS. No. | 570406-98-3 |
| Mol. Formula | C29H34Cl2N6O3S2 |
| Mol. Weight | 649.65 |
| Synonyms | NA |
| Chemical Name | 1-(3-Chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic acid |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | In Stock |
Avatrombopag is a synthetic small molecule thrombopoietin receptor agonist. Structurally, it is a tricyclic indole-based compound. Avatrombopag is designed to mimic the activity of endogenous thrombopoietin, a hormone that stimulates the production and maturation of platelets from megakaryocytes in the bone marrow. Chemically, avatrombopag is 1-(3-(4-((4-(1-piperidinyl)cyclohexyl)oxy)phenyl)-4,5-dihydro-5-(trifluoromethyl)-1H-pyrazol-1-yl)ethanone.Avatrombopag is approved for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a medical or dental procedure.Avatrombopag is administered orally and is typically initiated 10 to 13 days prior to the scheduled procedure and continued through the procedure. Buy high quality Avatrombopag from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Avatrombopag.